Literature DB >> 30091253

Italian consensus report on the aesthetic use of onabotulinum toxin A.

Dario Bertossi1, Maurizio Cavallini2, Pierfrancesco Cirillo3, Salvatore Piero Fundarò4, Sandro Quartucci3, Chantal Sciuto3, Davide Tonini5, Gloria Trocchi3, Massimo Signorini2.   

Abstract

BACKGROUND: The aesthetic treatment of facial and neck wrinkles with botulinum toxin is constantly increasing, thus making it necessary to collect procedures guidelines for the use of botulinum toxin in the treatment of wrinkles and/or cosmetic defects.
METHODS: A group of nine Italian doctors, plastic and maxillo-facial surgeons, dermatologists and aesthetic physicians, experts in face and neck aesthetic treatments with onabotulinum toxin A, discussed on procedures used in their clinical practice. From the data collected and discussed by the board, some recommendations on aesthetic treatment with onabotulinum toxin A were developed.
RESULTS: Recommendations have been made on pretreatment, reconstitution of onabotulinum toxin A, as well as on treatment procedures, in terms of injection sites and total dose of onabotulinum toxin A for the following indications: glabellar lines, crown's feet lines, forehead lines, eyebrow shaping, lower orbicularis oculi hypertrophy, bunny lines, sagging nasal tip, gummy smile, masseter hypertrophy, perioral lines, marionette lines, hypertonic mentalis, and platysma bands.
CONCLUSIONS: The use of onabotulinum toxin A in the aesthetic field requires careful initial assessment of the patient in its complexity and individuality. Moreover, this treatment needs the use of standardized procedures to achieve the effectiveness and safety of onabotulinum toxin A in clinical practice.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  aesthetic treatments; botulinum toxin; consensus

Mesh:

Substances:

Year:  2018        PMID: 30091253     DOI: 10.1111/jocd.12729

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  2 in total

1.  The effect of botulinum toxin A in patients with excessive gingival display with and without zinc supplementation: randomized clinical trial.

Authors:  Nesma Shemais; Azza Ezz Elarab; Hani ElNahass
Journal:  Clin Oral Investig       Date:  2021-05-05       Impact factor: 3.573

2.  A Retrospective Study Supporting the Importance of Individualizing the Dose of Botulinum Toxin According to the Age.

Authors:  Bruna Souza Felix Bravo; Raquel de Melo Carvalho; Bruna Fanton Gallo; Leonardo Gonçalves Bravo
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.